Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

19 Jul 2006 07:59

Investec Bank (UK) Limited19 July 2006 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in INTERSERVE PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 10,205 360.0 p 357.44 p (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected MACLELLAN GROUP PLCNature of connection (Note 6) ADVISER & BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in ENODIS PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 25,000 215.0 p 215.0 p (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected ENODIS PLCNature of connection (Note 6) JOINT BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in MACLELLAN GROUP PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 12,329 113.0 p 112.0 p Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected MACLELLAN GROUP PLCNature of connection (Note 6) ADVISER & BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Oct 20179:25 amRNSHolding(s) in Company
16th Oct 201710:04 amRNSDirector/PDMR Shareholding
16th Oct 20177:30 amRNSStatement following recent media coverage
12th Oct 20173:46 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSInterserve wins Leeds housing development contract
6th Oct 20179:08 amRNSHolding(s) in Company
5th Oct 20178:50 amRNSHolding(s) in Company
3rd Oct 20172:15 pmRNSDirector/PDMR Shareholding
3rd Oct 20177:00 amRNSInterserve-led consortium chosen for £85m project
2nd Oct 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Sep 201711:33 amRNSHolding(s) in Company
27th Sep 20177:00 amRNSInterserve wins place on £8bn CMA framework
26th Sep 201710:49 amRNSHolding(s) in Company
26th Sep 201710:42 amRNSHolding(s) in Company
20th Sep 20179:03 amRNSHolding(s) in Company
19th Sep 20174:26 pmRNSHolding(s) in Company
19th Sep 20179:45 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSHolding(s) in Company
18th Sep 20172:09 pmRNSDirector/PDMR Shareholding
18th Sep 20171:48 pmRNSHolding(s) in Company
18th Sep 201712:00 pmRNSDirector/PDMR Shareholding
18th Sep 201710:08 amRNSHolding(s) in Company
18th Sep 201710:04 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSMark Whiteling appointed Chief Financial Officer
15th Sep 20173:33 pmRNSHolding(s) in Company
15th Sep 20172:16 pmRNSDirector/PDMR Shareholding
14th Sep 20177:00 amRNSTrading Update
13th Sep 20179:18 amRNSDirector/PDMR Shareholding
12th Sep 201711:44 amRNSDirector/PDMR Shareholding
12th Sep 201710:16 amRNSHolding(s) in Company
11th Sep 201711:13 amRNSHolding(s) in Company
6th Sep 20179:24 amRNSHolding(s) in Company
6th Sep 20177:00 amRNSInterserve wins £90m DfT FM contract
1st Sep 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Aug 201711:42 amRNSHolding(s) in Company
24th Aug 20174:27 pmRNSHolding(s) in Company
24th Aug 201710:42 amRNSHolding(s) in Company
24th Aug 20179:18 amRNSPublication of Half-Year Report
24th Aug 20178:46 amRNSHolding(s) in Company
17th Aug 20179:33 amRNSHolding(s) in Company
16th Aug 20177:00 amRNSInterserve and Amec Foster Wheeler Joint Venture
14th Aug 20172:17 pmRNSHolding(s) in Company
14th Aug 20172:16 pmRNSHolding(s) in Company
9th Aug 20173:01 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSHalf-Year Results 2017
13th Jul 20174:25 pmRNSDirector/PDMR Shareholding
12th Jul 201712:52 pmRNSDirector/PDMR Shareholding
12th Jul 20179:44 amRNSHolding(s) in Company
3rd Jul 20177:00 amRNSBlock listing Interim Review
30th Jun 20177:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.